Cargando…
The Treatment Effectiveness Evaluation for Slowing the Progression of Diabetic Nephropathy During Stage 4 Chronic Kidney Disease
INTRODUCTION: People with advanced diabetic nephropathy (DN) are at high risk for development of end-stage renal disease (ESRD) or death. Whether renin-angiotensin system inhibitors and some concomitant drugs could still continue to delay the onset of ESRD in the later stage of DN needs to be clarif...
Autores principales: | Yu, Tianyu, Jiang, Shimin, Yang, Yue, Fang, Jinying, Zou, Guming, Gao, Hongmei, Zhuo, Li, Li, Wenge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843805/ https://www.ncbi.nlm.nih.gov/pubmed/33249545 http://dx.doi.org/10.1007/s13300-020-00970-3 |
Ejemplares similares
-
Activation of Complement Pathways in Kidney Tissue May Mediate Tubulointerstitial Injury in Diabetic Nephropathy
por: Jiang, Shimin, et al.
Publicado: (2022) -
Complement Deposition Predicts Worsening Kidney Function and Underlines the Clinical Significance of the 2010 Renal Pathology Society Classification of Diabetic Nephropathy
por: Jiang, Shimin, et al.
Publicado: (2022) -
Activation of complement C1q and C3 in glomeruli might accelerate the progression of diabetic nephropathy: Evidence from transcriptomic data and renal histopathology
por: Jiao, Yuanyuan, et al.
Publicado: (2022) -
Anti-neutrophil cytoplasmic antibody seropositivity in young adults aged up to 35 years: kidney histopathological findings and patient outcomes
por: Jiang, Shimin, et al.
Publicado: (2022) -
Lung cancer patients with nephropathy as the first manifestation: Literature review and clinical study report
por: Xu, Qianqian, et al.
Publicado: (2022)